(Total Views: 117)
Posted On: 06/21/2022 10:01:33 AM
Post# of 2

$GTSIF; CSE / $LOBED - Lobe Sciences plans to advance to Phase 1 PTSD study in second half of 2022 with psilocybin and NAC #BIO #SCIENCE #BioTechnology #investors #otc #nasdaq #wallstreet #psychedelic #research #PHARMA
https://youtu.be/gNKQi9oh5Ng
https://youtu.be/gNKQi9oh5Ng

